Imprimed
VerifiedProvides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$101—151m (Dealroom.co estimates Nov 2023.)
Company register number 6668701227
Palo Alto California (HQ)
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 19 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor investor investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
* | KRW30.0b | Series A | |
| Total Funding | 000k | ||
Related Content
Recent News about Imprimed
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.